source
- Corxel Group to go public in US by merging with SPAC, targeting oral GLP-1 marketCorxel Group announced that it will become a publicly traded company in the United States through a merger with a special purpose acquisition company. The move follows a similar SPAC transaction by…
- GLP-1 drugs enter trials to test impact on alcohol and drug cravingsGLP-1 drugs, first approved for diabetes and later for obesity, have sparked interest for broader therapeutic uses. Researchers are now launching large clinical trials to evaluate whether these ag…